• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/26 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Patent holdings for IPC class C07D 211/26

Total number of patents in this class: 380

10-year publication summary

23
28
35
20
19
12
24
14
22
10
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Novartis AG
10744
11
Concentric Analgesics, Inc.
23
11
Janssen Pharmaceutica N.V.
3394
10
Incyte Corporation
1022
10
Incyte Holdings Corporation
666
9
Glaxosmithkline Intellectual Property Development Limited
762
7
Boehringer Ingelheim International GmbH
4642
6
ChemoCentryx, Inc.
386
6
Richter Gedeon Nyrt.
1635
6
Praxis Precision Medicines, Inc.
174
6
Oryzon Genomics S.A.
106
5
Hoffmann-La Roche Inc.
3439
4
Glaxosmithkline Intellectual Property (no.2) Limited
287
4
Massachusetts Institute of Technology
10062
4
Astellas Pharma Inc.
1087
4
SK Biopharmaceuticals Co., Ltd.
262
4
Libertas bio, Inc.
17
4
F. Hoffmann-La Roche AG
7947
3
Merck Patent GmbH
5815
3
FUJIFILM Corporation
29437
3
Other owners 260